AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
In a recent study published in PNAS, researchers presented a scalable lipid nanoparticle (LNP) production (SCALAR) platform to produce high-throughput lipid nanoparticles on one microfluidic chip and ...
Waterfall Scientific, a biotechnology company pioneering continuous-flow RNA manufacturing technologies, today announced that it has been selected by the Advanced Research Projects Agency for Health ...
Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, acquired Blacktrace Holdings today. For decades, Blacktrace’s ...
Nucleic acids (e.g., siRNA, mRNA and saRNA) can be designed and formulated to silence, express, and edit specific genes providing a flexible and powerful approach to preventing and treating diseases.
Earli is using Particle Works’ ALiS and ANP System to accelerate and optimize DNA-LNP formulation screening for potential cancer. The team at Earli is looking forward to using its new Particle Works ...
Researchers have developed a freely available droplet microfluidic component library, which promises to transform the way microfluidic devices are created. This innovation, based on low-cost rapid ...
Engineers have developed an automated microfluidic platform that dramatically accelerates the formulation of lipid nanoparticles, the delivery vehicles behind mRNA vaccines and gene therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results